Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | CTSK | P43235 | 4/20 | 0.52 |
| ▸ | CTSS | P25774 | 3/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8971989 | 0.85 | TRPA1 (0.57) | CA2CTSKCTSSTRPA1LMNA | |
| SCHEMBL8194722 | 0.84 | CA2 (0.57) | CA2CTSKCTSSTRPA1LMNA | |
| SCHEMBL28969869 | 0.76 | CTSK (0.67) | CA2CTSKCTSSCTSL | |
| SCHEMBL5559974 | 0.76 | CTSK (0.67) | CA2CTSKCTSSCTSL | |
| SCHEMBL25069089 | 0.75 | CTSS (0.52) | CA2CTSKCTSSTRPA1LMNA | |
| SCHEMBL26814991 | 0.75 | CTSS (0.52) | CA2CTSKCTSSTRPA1LMNA | |
| SCHEMBL30340914 | 0.75 | ALDH1A1 (0.58) | CA2CTSKCTSSTRPA1LMNA | |
| SCHEMBL13664903 | 0.75 | ALDH1A1 (0.58) | CA2CTSKCTSSTRPA1LMNA | |
| SCHEMBL26503173 | 0.75 | ALDH1A1 (0.58) | CA2CTSKCTSSTRPA1LMNA | |
| SCHEMBL8416665 | 0.75 | CA2 (0.72) | CA2CTSKCTSSLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008033389-A2 | MACROCYCLIC HCV INHIBITORS AND THEIR USES | NOVARTIS AG (CH) | 2008-03-20 | — | — | WO | disclosed |